Myriad Genetics (MYGN) Gross Margin (2009 - 2026)
Myriad Genetics (MYGN) reported Gross Margin of 68.66% for Q1 2026, up 16.0% year-over-year from 59.19% in Q1 2025, and down 1.87% quarter-over-quarter from 69.97% in Q4 2025.
Myriad Genetics (MYGN) Gross Margin (2009 - 2026) Analysis & Trends
Myriad Genetics (MYGN) has 18 years of Gross Margin data on file, last reported at 68.66% in Q1 2026.
- Gross Margin for Q1 2026 came in at 68.66%, up 16.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 69.96% (down 5.0% YoY), and the FY2025 annual result was 69.93%, up 4.0% from the prior year.
- Gross Margin retreated to 68.66% in Q1 2026 per MYGN's latest filing, from 69.97% in the prior quarter.
- Over five years, Gross Margin peaked at 72.28% in Q2 2022 and troughed at 33.24% in Q4 2022.
- A 5-year average of 65.85% and a median of 69.55% in 2024 frame the typical range for Gross Margin.
- The sharpest annual moves came in 2022 and 2024: Gross Margin slumped 14636 bps in 2022, then jumped 2994 bps in 2024.
- A 5-year view of Gross Margin shows it stood at 33.24% in 2022, then climbed by 25 bps to 41.71% in 2023, then soared by 72 bps to 71.65% in 2024, then decreased by 2 bps to 69.97% in 2025, then dropped by 2 bps to 68.66% in 2026.
- Business Quant data shows MYGN's Gross Margin at 68.66% in Q1 2026, 69.97% in Q4 2025, and 69.91% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 29,902.70 Bn | 29,902.24 Bn | 1.11 Bn | 87.77% |
| 2 | Thermo Fisher Scientific | 175.99 Bn | 172.74 Bn | 7.74 Bn | 70.37% |
| 3 | Danaher | 129.87 Bn | 124.18 Bn | 3.59 Bn | 60.34% |
| 4 | Idexx Laboratories | 44.75 Bn | 44.55 Bn | 722.74 Mn | 63.35% |
| 5 | Agilent Technologies | 37.52 Bn | 35.72 Bn | 990.00 Mn | 53.95% |
| 6 | Iqvia Holdings | 30.91 Bn | 28.94 Bn | 1.36 Bn | 32.64% |
| 7 | Natera | 30.21 Bn | 29.11 Bn | 696.04 Mn | 99.91% |
| 8 | Illumina | 24.19 Bn | 23.04 Bn | 721.00 Mn | 66.09% |
| 9 | Mettler Toledo International | 23.12 Bn | 23.06 Bn | 555.82 Mn | 58.68% |
| 10 | Myriad Genetics | 411.34 Mn | 286.94 Mn | 137.60 Mn | 68.66% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 68.66% |
| Dec 31, 2025 | 69.97% |
| Sep 30, 2025 | 69.91% |
| Jun 30, 2025 | 71.23% |
| Mar 31, 2025 | 68.50% |
| Dec 31, 2024 | 71.65% |
| Sep 30, 2024 | 70.23% |
| Jun 30, 2024 | 69.55% |
| Mar 31, 2024 | 68.05% |
| Dec 31, 2023 | 41.71% |
| Sep 30, 2023 | 69.98% |
| Jun 30, 2023 | 68.50% |
| Mar 31, 2023 | 67.33% |
| Dec 31, 2022 | 33.24% |
| Sep 30, 2022 | 67.77% |
| Jun 30, 2022 | 72.28% |
| Mar 31, 2022 | 70.89% |
| Dec 31, 2021 | 179.60% |
| Sep 30, 2021 | 100.00% |
| Jun 30, 2021 | 74.66% |